Rapid in vivo measurement of ß-amyloid reveals biphasic clearance kinetics in an Alzheimer's mouse model

Carla M. Yuede, Hyo Lee, Jessica L. Restivo, Todd A. Davis, Jane C. Hettinger, Clare E. Wallace, Katherine L. Young, Margaret R. Hayne, Guojun D Bu, Chen zhong Li, John R. Cirrito

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Findings from genetic, animal model, and human studies support the observation that accumulation of the ß-amyloid (Aß) peptide in the brain plays a central role in the pathogenic cascade of Alzheimer's disease (AD). Human studies suggest that one key factor leading to accumulation is a defect in brain Aß clearance. We have developed a novel microimmunoelectrode (MIE) to study the kinetics of Aß clearance using an electrochemical approach. This is the first study using MIEs in vivo to measure rapid changes in Aß levels in the brains of living mice. Extracellular, interstitial fluid (ISF) Aß levels were measured in the hippocampus of APP/PS1 mice. Baseline levels of Aß40 in the ISF are relatively stable and begin to decline within minutes of blocking Aß production with a γ-secretase inhibitor. Pretreatment with a P-glycoprotein inhibitor, which blocks blood-brain barrier transport of Aß, resulted in significant prolongation of Aß40 half-life, but only in the latter phase of Aß clearance from the ISF.

Original languageEnglish (US)
Pages (from-to)677-685
Number of pages9
JournalJournal of Experimental Medicine
Volume213
Issue number5
DOIs
StatePublished - 2016

Fingerprint

Extracellular Fluid
Amyloid
Brain
Amyloid Precursor Protein Secretases
Genetic Models
P-Glycoprotein
Blood-Brain Barrier
Half-Life
Hippocampus
Alzheimer Disease
Animal Models
Peptides

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Yuede, C. M., Lee, H., Restivo, J. L., Davis, T. A., Hettinger, J. C., Wallace, C. E., ... Cirrito, J. R. (2016). Rapid in vivo measurement of ß-amyloid reveals biphasic clearance kinetics in an Alzheimer's mouse model. Journal of Experimental Medicine, 213(5), 677-685. https://doi.org/10.1084/jem.20151428

Rapid in vivo measurement of ß-amyloid reveals biphasic clearance kinetics in an Alzheimer's mouse model. / Yuede, Carla M.; Lee, Hyo; Restivo, Jessica L.; Davis, Todd A.; Hettinger, Jane C.; Wallace, Clare E.; Young, Katherine L.; Hayne, Margaret R.; Bu, Guojun D; Li, Chen zhong; Cirrito, John R.

In: Journal of Experimental Medicine, Vol. 213, No. 5, 2016, p. 677-685.

Research output: Contribution to journalArticle

Yuede, CM, Lee, H, Restivo, JL, Davis, TA, Hettinger, JC, Wallace, CE, Young, KL, Hayne, MR, Bu, GD, Li, CZ & Cirrito, JR 2016, 'Rapid in vivo measurement of ß-amyloid reveals biphasic clearance kinetics in an Alzheimer's mouse model', Journal of Experimental Medicine, vol. 213, no. 5, pp. 677-685. https://doi.org/10.1084/jem.20151428
Yuede, Carla M. ; Lee, Hyo ; Restivo, Jessica L. ; Davis, Todd A. ; Hettinger, Jane C. ; Wallace, Clare E. ; Young, Katherine L. ; Hayne, Margaret R. ; Bu, Guojun D ; Li, Chen zhong ; Cirrito, John R. / Rapid in vivo measurement of ß-amyloid reveals biphasic clearance kinetics in an Alzheimer's mouse model. In: Journal of Experimental Medicine. 2016 ; Vol. 213, No. 5. pp. 677-685.
@article{a648d0bed5e94f459fcda1c28f258bee,
title = "Rapid in vivo measurement of {\ss}-amyloid reveals biphasic clearance kinetics in an Alzheimer's mouse model",
abstract = "Findings from genetic, animal model, and human studies support the observation that accumulation of the {\ss}-amyloid (A{\ss}) peptide in the brain plays a central role in the pathogenic cascade of Alzheimer's disease (AD). Human studies suggest that one key factor leading to accumulation is a defect in brain A{\ss} clearance. We have developed a novel microimmunoelectrode (MIE) to study the kinetics of A{\ss} clearance using an electrochemical approach. This is the first study using MIEs in vivo to measure rapid changes in A{\ss} levels in the brains of living mice. Extracellular, interstitial fluid (ISF) A{\ss} levels were measured in the hippocampus of APP/PS1 mice. Baseline levels of A{\ss}40 in the ISF are relatively stable and begin to decline within minutes of blocking A{\ss} production with a γ-secretase inhibitor. Pretreatment with a P-glycoprotein inhibitor, which blocks blood-brain barrier transport of A{\ss}, resulted in significant prolongation of A{\ss}40 half-life, but only in the latter phase of A{\ss} clearance from the ISF.",
author = "Yuede, {Carla M.} and Hyo Lee and Restivo, {Jessica L.} and Davis, {Todd A.} and Hettinger, {Jane C.} and Wallace, {Clare E.} and Young, {Katherine L.} and Hayne, {Margaret R.} and Bu, {Guojun D} and Li, {Chen zhong} and Cirrito, {John R.}",
year = "2016",
doi = "10.1084/jem.20151428",
language = "English (US)",
volume = "213",
pages = "677--685",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "5",

}

TY - JOUR

T1 - Rapid in vivo measurement of ß-amyloid reveals biphasic clearance kinetics in an Alzheimer's mouse model

AU - Yuede, Carla M.

AU - Lee, Hyo

AU - Restivo, Jessica L.

AU - Davis, Todd A.

AU - Hettinger, Jane C.

AU - Wallace, Clare E.

AU - Young, Katherine L.

AU - Hayne, Margaret R.

AU - Bu, Guojun D

AU - Li, Chen zhong

AU - Cirrito, John R.

PY - 2016

Y1 - 2016

N2 - Findings from genetic, animal model, and human studies support the observation that accumulation of the ß-amyloid (Aß) peptide in the brain plays a central role in the pathogenic cascade of Alzheimer's disease (AD). Human studies suggest that one key factor leading to accumulation is a defect in brain Aß clearance. We have developed a novel microimmunoelectrode (MIE) to study the kinetics of Aß clearance using an electrochemical approach. This is the first study using MIEs in vivo to measure rapid changes in Aß levels in the brains of living mice. Extracellular, interstitial fluid (ISF) Aß levels were measured in the hippocampus of APP/PS1 mice. Baseline levels of Aß40 in the ISF are relatively stable and begin to decline within minutes of blocking Aß production with a γ-secretase inhibitor. Pretreatment with a P-glycoprotein inhibitor, which blocks blood-brain barrier transport of Aß, resulted in significant prolongation of Aß40 half-life, but only in the latter phase of Aß clearance from the ISF.

AB - Findings from genetic, animal model, and human studies support the observation that accumulation of the ß-amyloid (Aß) peptide in the brain plays a central role in the pathogenic cascade of Alzheimer's disease (AD). Human studies suggest that one key factor leading to accumulation is a defect in brain Aß clearance. We have developed a novel microimmunoelectrode (MIE) to study the kinetics of Aß clearance using an electrochemical approach. This is the first study using MIEs in vivo to measure rapid changes in Aß levels in the brains of living mice. Extracellular, interstitial fluid (ISF) Aß levels were measured in the hippocampus of APP/PS1 mice. Baseline levels of Aß40 in the ISF are relatively stable and begin to decline within minutes of blocking Aß production with a γ-secretase inhibitor. Pretreatment with a P-glycoprotein inhibitor, which blocks blood-brain barrier transport of Aß, resulted in significant prolongation of Aß40 half-life, but only in the latter phase of Aß clearance from the ISF.

UR - http://www.scopus.com/inward/record.url?scp=84969262537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969262537&partnerID=8YFLogxK

U2 - 10.1084/jem.20151428

DO - 10.1084/jem.20151428

M3 - Article

VL - 213

SP - 677

EP - 685

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 5

ER -